Premier Research Contributed to the 13th World Congress on Pain

PHILADELPHIA, Sept. 29 /PRNewswire/ -- Premier Research Group Limited, an international CRO with unrivaled analgesia research expertise, recently contributed to the 13th World Congress on Pain. Dr. Stephen Daniels, Executive Medical Director, co-authored six posters presented at the meeting. The posters are available on the company website.

Dr. Stephen Daniels has served as Principal Investigator on more than 200 clinical trials in acute and chronic pain and general medicine as well as providing client consultation regarding the design and implementation of acute pain trials. Over his 17 year career, he has served as author/co-author on numerous posters, abstracts and manuscripts in the area of analgesia including postoperative pain and dysmenorrhea.  

In addition to the full service CRO offerings, Premier Research owns and operates three clinical research centers in Austin, TX, Salt Lake City, UT and Peoria, AZ designed to offer clinical site services from Phase 1 POC trials to Phase 4 post-marketing trials primarily in the areas of analgesia, rheumatology, neuroscience and oncology. Premier Research has conducted more than 350 pain and arthritis studies involving mechanistically-novel pharmacologic agents as well as innovative formulation and drug delivery systems for analgesics.

Since Premier Research has helped pioneer the development of new research models and pain assessment methodologies, the company helps clients identify appropriate endpoints, study design, and the overall clinical development plan for their products.

In addition, the company offers unparalleled support with pediatric pain research and assistance with PREA commitments and BPCA written requests.  This includes development of pediatric plans and protocols, waiver requests, study feasibility and expertise with respect to the FDA Pediatric Review Committee (PeRC).

About Premier Research

Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. With skilled staff operating across North America and Europe and partnerships in Latin America, Asia, South Africa, Australia and the Middle East, Premier Research manages Phase 1-4 trials and programs.

They are leaders in clinical research for analgesia, oncology, neuroscience, and cardiovascular and have a wealth of experience in medical device and pediatric research. They offer a comprehensive selection of services for every development phase including, regulatory affairs, clinical trial management, clinical research centers, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, IVRS/IWRS, quality assurance, and functional sourcing.

www.premier-research.com

SOURCE Premier Research Group Limited